Author:
Dakin Helen,Fidler Carrie,Harper Christie
Subject
Public Health, Environmental and Occupational Health,Health Policy
Reference77 articles.
1. EASL clinical practice guidelines: management of chronic hepatitis B;European Association For The Study Of The Liver;J Hepatol,2009
2. British National Formulary (BNF), No. 57;British Medical Association,2009
3. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B;Chang;N Engl J Med,2006
4. Leung N, Peng CY, Sollano J, et al. Entecavir (ETV) results in higher HBV-DNA reduction vs adefovir (ADV) in CHRONICALLY Infected HBeAg+ antiviral-naïve adults: 48 week results (E.A.R.L.Y. Study). Podium presentation at the 42nd Annual Meeting of the European Association for the Study of the Liver April 11–15, 2007 Barcelona, Spain. 2007, Oral No. 49.
5. Entecavir is superior to lamivudine for the treatment of chronic hepatitis B (CHB): results of a phase 3 Chinese study (ETV-023) in nucleoside-naive patients;Yao;J Hepatol,2006
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献